ElectroCore, Inc.

ElectroCore, Inc. is a bioelectronic medicine company that develops non-invasive vagus nerve stimulation (nVNS) therapies. These therapies are primarily designed for the treatment of neurology and rheumatology conditions. ElectroCore's flagship product, gammaCore, offers a portable, hand-held medical device that delivers nVNS to help alleviate symptoms associated with chronic and episodic cluster headaches and migraines. The device is used as an alternative or complement to traditional pharmacological treatments, addressing unmet needs in pain management without the side effects often linked to medication. ElectroCore’s innovative approach focuses on noninvasive solutions, providing significant benefits in patient compliance and quality of life. In the pharmaceutical and health care market, ElectroCore is continuously exploring and expanding its therapeutic applications, including overactive bladder and post-traumatic stress disorder (PTSD). As a pivotal player in the emerging field of bioelectronic medicine, ElectroCore contributes to shaping future therapies that leverage neuromodulation to treat various medical conditions, marking a transformative approach in medical technology. Headquartered in Basking Ridge, New Jersey, ElectroCore plays a vital role in advancing non-drug treatment modalities and enhancing modern medical treatments.